Icon to restore staff pay as business recovers from virus
Clinical trials firm reported 10.8% drop in revenues for the three months to the end of June
Icon, the Dublin-headquartered clinical trials company, is to restore pay for staff as business recovers from the Covid-19 pandemic.
The company, which employs 15,000 people, took an $18 million (€15.5 million) restructuring charge in the second quarter of the year as it cut costs to deal with Covid-19’s impact. As well as putting a freeze on hiring, the firm reduced contract employees and cut some staff salaries.
“These decisions were not taken lightly at that...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Malin shareholders in line for windfall after €119 million cash boost
Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year
Amryt seeks to have rare condition drug approved for payment
The Dublin company is in discussion with regulators in Britain and France to have metreleptin, a treatment for abnormal distribution of fat in the body, approved for payment reimbursement
Comment: Cutting-edge pharma research can bring investment to Ireland
We have the potential to become Europe’s go-to destination for the development of advanced therapy medicinal products